- Home
- KVYO vs ASND Comparison
KVYO vs ASND Comparison
Compare KVYO & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVYO
- ASND
- Stock Information
- Founded
- KVYO 2012
- ASND 2006
- Country
- KVYO United States
- ASND Denmark
- Employees
- KVYO N/A
- ASND N/A
- Industry
- KVYO
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- KVYO
- ASND Health Care
- Exchange
- KVYO Nasdaq
- ASND Nasdaq
- Market Cap
- KVYO 9.6B
- ASND 10.6B
- IPO Year
- KVYO 2023
- ASND 2015
- Fundamental
- Price
- KVYO $31.59
- ASND $190.37
- Analyst Decision
- KVYO Strong Buy
- ASND Strong Buy
- Analyst Count
- KVYO 22
- ASND 16
- Target Price
- KVYO $43.59
- ASND $239.88
- AVG Volume (30 Days)
- KVYO 2.7M
- ASND 550.9K
- Earning Date
- KVYO 08-05-2025
- ASND 08-07-2025
- Dividend Yield
- KVYO N/A
- ASND N/A
- EPS Growth
- KVYO N/A
- ASND N/A
- EPS
- KVYO N/A
- ASND N/A
- Revenue
- KVYO $1,078,202,000.00
- ASND $576,332,355.00
- Revenue This Year
- KVYO $27.90
- ASND $101.37
- Revenue Next Year
- KVYO $21.02
- ASND $76.17
- P/E Ratio
- KVYO N/A
- ASND N/A
- Revenue Growth
- KVYO 33.17
- ASND 54.50
- 52 Week Low
- KVYO $23.77
- ASND $111.09
- 52 Week High
- KVYO $49.55
- ASND $199.99
- Technical
- Relative Strength Index (RSI)
- KVYO 48.17
- ASND 56.22
- Support Level
- KVYO $30.39
- ASND $191.44
- Resistance Level
- KVYO $33.30
- ASND $197.35
- Average True Range (ATR)
- KVYO 1.48
- ASND 8.17
- MACD
- KVYO 0.09
- ASND -0.26
- Stochastic Oscillator
- KVYO 25.29
- ASND 61.21
About KVYO Klaviyo Inc. Series A
Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.